| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Patrick D Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful Syed, Brian Pittman, Deepak C D'Souz. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. Journal of psychopharmacology (Oxford, England). 2023-07-01. PMID:37392016. |
sub-acute effects of psilocybin on eeg correlates of neural plasticity in major depression: relationship to symptoms. |
2023-07-01 |
2023-08-14 |
Not clear |
| Harrison J Lee, Vivian Wl Tsang, Brandon S Chai, Michelle Cq Lin, Andrew Howard, Christopher Uy, Julius O Elefant. Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review. Journal of psychoactive drugs. 2023-06-29. PMID:37385217. |
psilocybin's potential mechanisms in the treatment of depression: a systematic review. |
2023-06-29 |
2023-08-14 |
human |
| Harrison J Lee, Vivian Wl Tsang, Brandon S Chai, Michelle Cq Lin, Andrew Howard, Christopher Uy, Julius O Elefant. Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review. Journal of psychoactive drugs. 2023-06-29. PMID:37385217. |
evidence suggests that psilocybin has therapeutic benefit for treating depression. |
2023-06-29 |
2023-08-14 |
human |
| Rich Harid. Australia to prescribe MDMA and psilocybin for PTSD and depression in world first. Nature. 2023-06-29. PMID:37386185. |
australia to prescribe mdma and psilocybin for ptsd and depression in world first. |
2023-06-29 |
2023-08-14 |
Not clear |
| Anya Borissova, James J Rucke. The development of psilocybin therapy for treatment-resistant depression: an update. BJPsych bulletin. 2023-06-26. PMID:37357767. |
the development of psilocybin therapy for treatment-resistant depression: an update. |
2023-06-26 |
2023-08-14 |
human |
| Anya Borissova, James J Rucke. The development of psilocybin therapy for treatment-resistant depression: an update. BJPsych bulletin. 2023-06-26. PMID:37357767. |
initial phase 2 clinical trials of psilocybin given alongside psychological support for major depression and treatment-resistant depression (trd) demonstrated encouraging signs of basic safety, further confirmed by a large study in groups of healthy volunteers. |
2023-06-26 |
2023-08-14 |
human |
| Sandeep M Nayak, Bilal A Bari, David B Yaden, Meg J Spriggs, Fernando E Rosas, Joseph M Peill, Bruna Giribaldi, David Erritzoe, David J Nutt, Robin Carhart-Harri. A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression. Psychedelic medicine (New Rochelle, N.Y.). vol 1. issue 1. 2023-06-20. PMID:37337526. |
a bayesian reanalysis of a trial of psilocybin versus escitalopram for depression. |
2023-06-20 |
2023-08-14 |
Not clear |
| Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy, Michelle Baker-Jones, Jonny Martell, David J Nutt, Robin L Carhart-Harris, David Erritzo. Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression. Psychological medicine. 2023-06-02. PMID:37264814. |
personality change in a trial of psilocybin therapy v. escitalopram treatment for depression. |
2023-06-02 |
2023-08-14 |
Not clear |
| Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne K Schlag, David J Nutt, Joanna C Neil. Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model. Psychological medicine. 2023-06-02. PMID:37264950. |
there is growing evidence to support the use of the psychedelic drug psilocybin for difficult-to-treat depression. |
2023-06-02 |
2023-08-14 |
Not clear |
| Olivier Brow. Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression". Journal of affective disorders. 2023-05-31. PMID:37257781. |
letter to the editor on "increased low-frequency brain responses to music after psilocybin therapy for depression". |
2023-05-31 |
2023-08-14 |
Not clear |
| Olivier Brow. Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression". Journal of affective disorders. 2023-05-31. PMID:37257781. |
the recent publication in the journal of affective disorders titled "increased low-frequency brain responses to music after psilocybin therapy for depression" identified significant region-of-interest based effects of treatment in the task scans. |
2023-05-31 |
2023-08-14 |
Not clear |
| Olivier Brow. Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression". Journal of affective disorders. 2023-05-31. PMID:37257781. |
these concerns raise questions as to the impact of confounds, including as age and biological sex, on the reported proportion variance explained by the effects of psilocybin treatment for depression. |
2023-05-31 |
2023-08-14 |
Not clear |
| D J Heal, S L Smith, S J Belouin, J E Henningfiel. Psychedelics: Threshold of a Therapeutic Revolution. Neuropharmacology. 2023-05-29. PMID:37247807. |
the us food and drug administration (fda) has granted two breakthrough therapy designations for psilocybin in treatment resistant depression (trd) in 2018 and major depressive disorder (mdd) in 2019, as well as for mdma for the treatment of post-traumatic stress disorder (ptsd) in 2017. |
2023-05-29 |
2023-08-14 |
human |
| Kamyar Keramatian, Trisha Chakrabarty, Anais DuBois, Gayatri Saraf, Lakshmi N Yatha. New Pharmacologic Approaches to the Treatment of Bipolar Depression. Drugs. 2023-05-25. PMID:37227597. |
there are currently no adequately powered rcts of zuranolone, psilocybin or cbd in bd depression to support their use. |
2023-05-25 |
2023-08-14 |
Not clear |
| Saleha Qasim, Zaofashan Zaheer, Muhammad Youshay Jawad, Mujeeb U Sha. Neurobiological Correlates of Psilocybin Response in Depression. The primary care companion for CNS disorders. vol 25. issue 3. 2023-05-25. PMID:37230065. |
neurobiological correlates of psilocybin response in depression. |
2023-05-25 |
2023-08-14 |
Not clear |
| Brandon Weiss, David Erritzoe, Bruna Giribaldi, David J Nutt, Robin L Carhart-Harri. A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. Journal of psychopharmacology (Oxford, England). 2023-05-01. PMID:37122239. |
a critical evaluation of qids-sr-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. |
2023-05-01 |
2023-08-14 |
Not clear |
| Jonathan Joseph Dawood Hristova, Virtudes Pérez-Jove. Psychotherapy with Psilocybin for Depression: Systematic Review. Behavioral sciences (Basel, Switzerland). vol 13. issue 4. 2023-04-27. PMID:37102811. |
psychotherapy with psilocybin for depression: systematic review. |
2023-04-27 |
2023-08-14 |
Not clear |
| Matthew B Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David J Nutt, Robin L Carhart-Harri. Increased low-frequency brain responses to music after psilocybin therapy for depression. Journal of affective disorders. 2023-04-24. PMID:37094657. |
increased low-frequency brain responses to music after psilocybin therapy for depression. |
2023-04-24 |
2023-08-14 |
Not clear |
| Manish Agrawal, Ezekiel Emanuel, Brian Richards, William Richards, Kim Roddy, Paul Thamb. Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder. JAMA oncology. 2023-04-13. PMID:37052904. |
assessment of psilocybin therapy for patients with cancer and major depression disorder. |
2023-04-13 |
2023-08-14 |
Not clear |
| Franklin R Schneier, Jamie Feusner, Michael G Wheaton, Gloria J Gomez, Giselle Cornejo, Akansha Mahesh Naraindas, David J Hellerstei. Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. Journal of psychiatric research. vol 161. 2023-04-02. PMID:37004409. |
psilocybin is a psychedelic drug with growing evidence for safety and efficacy in treatment of depression. |
2023-04-02 |
2023-08-14 |
Not clear |